SI-BONE, Inc.
SI-BONE, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 33 | 34 | 42 | 26 | 34 | 41 | 35 | 30 | 26 | 32 | 33 | 53 | |||||
Debt Securities Available For Sale Excluding Accru… | 113 | 111 | 106 | 119 | 111 | 103 | 115 | 121 | 126 | 126 | 133 | 113 | |||||
Accounts Receivable Net Current | 31 | 31 | 30 | 27 | 24 | 27 | 27 | 25 | 25 | 22 | 22 | 20 | |||||
Inventory Net | 38 | 36 | 34 | 36 | 34 | 30 | 27 | 26 | 23 | 21 | 20 | 22 | |||||
Prepaid Expense And Other Assets Current | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 2 | |||||
Assets Current | 220 | 215 | 216 | 211 | 207 | 204 | 208 | 204 | 202 | 204 | 211 | 211 | |||||
Property Plant And Equipment Net | 22 | 20 | 21 | 22 | 22 | 21 | 20 | 21 | 19 | 17 | 16 | 16 | |||||
Operating Lease Right Of Use Asset | 7 | 7 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | |||||
Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 249 | 243 | 239 | 234 | 231 | 227 | 230 | 227 | 224 | 224 | 230 | 231 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 9 | 7 | 5 | 8 | 7 | 8 | 6 | 7 | 7 | 8 | 5 | 4 | |||||
Accrued Liabilities Current | 15 | 14 | 20 | 18 | 16 | 15 | 19 | 16 | 13 | 12 | 17 | 14 | |||||
Operating Lease Liability Current | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities Current | 24 | 21 | 25 | 26 | 25 | 24 | 27 | 25 | 22 | 21 | 23 | 19 | |||||
Long Term Debt Noncurrent | 36 | 36 | 36 | 36 | 36 | 35 | 35 | 36 | 36 | 36 | 36 | 36 | |||||
Operating Lease Liability Noncurrent | 7 | 7 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | |||||
Other Liabilities Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 66 | 64 | 61 | 62 | 61 | 60 | 63 | 62 | 59 | 58 | 61 | 57 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 641 | 633 | 627 | 620 | 614 | 605 | 598 | 591 | 585 | 577 | 569 | 563 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | |||||
Retained Earnings Accumulated Deficit | -459 | -455 | -450 | -449 | -444 | -438 | -431 | -427 | -420 | -411 | -400 | -389 | |||||
Stockholders Equity | 182 | 179 | 178 | 172 | 170 | 167 | 167 | 165 | 165 | 166 | 169 | 174 | |||||
Liabilities And Stockholders Equity | 249 | 243 | 239 | 234 | 231 | 227 | 230 | 227 | 224 | 224 | 230 | 231 | |||||
Allowance For Doubtful Accounts Receivable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |||||
Common Stock Shares Issued | 45 | 44 | 44 | 43 | 43 | 42 | 42 | 42 | 42 | 41 | 41 | 40 | |||||
Shares Outstanding | 45 | 44 | 44 | 43 | 43 | 42 | 42 | 42 | 42 | 41 | 41 | 40 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 30.23% | 47.37% | 52.97% | - | - | - | - | - | - | - | - | - |
| 2025 | 14.89% | 12.04% | 4.86% | 4.19% | -12.19% | -3.19% | 25.51% | 26.21% | 5.74% | -16.35% | -7.85% | -7.39% |
| 2024 | -10.40% | -17.54% | 3.06% | 16.88% | -5.91% | -10.90% | -13.50% | -8.70% | 7.23% | -20.50% | -24.89% | 7.32% |
| 2023 | - | - | - | 8.55% | 1.97% | -19.20% | 9.93% | 22.61% | 14.31% | -14.13% | -13.18% | -15.99% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 9.15 | 9.99 | 8.55 | 7.97 | 8.38 | 8.53 | 7.66 | 8.25 | 9.17 | 9.76 | 9.01 | 10.89 | |||||
| Quick Ratio | 7.37 | 8.17 | 7.03 | 6.52 | 6.87 | 7.14 | 6.54 | 7.12 | 7.99 | 8.63 | 8.01 | 9.64 | |||||
| Working Capital | 195.87M | 193.23M | 190.84M | 184.34M | 182.70M | 180.25M | 180.65M | 179.02M | 180.27M | 182.77M | 187.94M | 191.65M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.36 | 0.36 | 0.34 | 0.36 | 0.36 | 0.36 | 0.38 | 0.38 | 0.36 | 0.35 | 0.36 | 0.33 | |||||
| Interest Coverage TTM | -7.13 | -7.80 | -8.50 | -9.08 | -9.18 | -9.53 | -10.25 | -11.95 | -12.96 | -13.60 | -13.56 | -13.24 | |||||
| Debt Ratio | 0.27 | 0.26 | 0.26 | 0.27 | 0.26 | 0.26 | 0.28 | 0.27 | 0.26 | 0.26 | 0.26 | 0.25 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.89 | 0.88 | 0.86 | 0.84 | 0.81 | 0.78 | 0.73 | 0.69 | 0.66 | 0.77 | 0.72 | 0.68 | |||||
| Days Sales Outstanding TTM | 47.46 | 51.03 | 52.11 | 48.50 | 48.43 | 50.44 | 53.94 | 52.18 | 54.76 | 56.64 | 56.01 | 50.39 | |||||
| Receivables Turnover TTM | 7.69 | 7.15 | 7.00 | 7.53 | 7.54 | 7.24 | 6.77 | 7.00 | 6.67 | 6.44 | 6.52 | 7.24 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.33 | -0.38 | -0.44 | -0.50 | -0.56 | -0.63 | -0.75 | -0.90 | -0.99 | -1.05 | -1.13 | -1.08 | |||||
| Free Cash Flow Per Share TTM | -0.18 | -0.13 | -0.21 | -0.08 | -0.13 | -0.48 | -0.55 | -0.60 | -0.63 | -0.56 | -0.69 | -0.78 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 79.53% | 79.59% | 79.57% | 79.62% | 79.45% | 79.25% | 79.03% | 77.70% | 77.69% | 78.10% | 78.78% | 81.53% | |||||
| Operating Profit Margin TTM | -8.31% | -9.67% | -11.11% | -13.10% | -14.90% | -17.38% | -21.08% | -26.91% | -30.39% | -33.10% | -33.79% | -34.64% | |||||
| Net Profit Margin TTM | -6.85% | -8.10% | -9.41% | -11.24% | -12.83% | -15.03% | -18.49% | -23.82% | -27.10% | -29.93% | -31.20% | -32.98% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 15.30% | 16.77% | 20.19% | 23.27% | 22.93% | 22.60% | 20.37% | 18.98% | 21.15% | 23.46% | 30.52% | 32.40% | |||||
| Net Income Growth (1Y) | -38.43% | -37.12% | -38.85% | -41.83% | -41.82% | -38.42% | -28.67% | -14.08% | -14.30% | -21.57% | -29.25% | -32.58% | |||||
| EPS Growth (1Y) | -40.77% | -39.44% | -40.97% | -43.81% | -43.82% | -40.46% | -33.89% | -17.07% | -21.46% | -33.10% | -37.03% | -42.47% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -49.61 | -33.25 | -44.81 | -29.22 | -33.89 | -22.37 | -18.81 | -15.59 | -13.08 | -15.54 | -18.61 | -19.65 | |||||
| P/B TTM | 3.98 | 3.10 | 4.77 | 3.69 | 4.73 | 3.55 | 3.48 | 3.54 | 3.24 | 4.05 | 4.76 | 4.93 | |||||
| P/S TTM | 3.40 | 2.69 | 4.22 | 3.28 | 4.35 | 3.36 | 3.48 | 3.71 | 3.54 | 4.65 | 5.81 | 6.48 | |||||
| Market Cap | 725.87M | 555.21M | 847.17M | 635.74M | 805.27M | 593.99M | 581.36M | 583.21M | 534.24M | 670.10M | 806.59M | 855.24M | |||||
| Enterprise Value | 728.37M | 557.28M | 840.50M | 644.79M | 806.63M | 588.29M | 581.87M | 589.18M | 544.81M | 674.16M | 809.39M | 837.77M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -7.93M | -5.55M | -9.09M | -3.63M | -5.75M | -20.25M | -22.92M | -25.22M | -25.98M | -22.83M | -26.51M | -31.56M | |||||
| Net Debt | 2.50M | 2.06M | -6.67M | 9.05M | 1.36M | -5.71M | 504.00K | 5.97M | 10.57M | 4.07M | 2.79M | -17.47M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
SI-BONE, Inc. (SIBN) — SEC Financial Statements & Analysis
SI-BONE, Inc. (SIBN) is a surgical & medical instruments & apparatus company, incorporated in DE. SI-BONE, Inc. trades on Nasdaq as: SIBN. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), SI-BONE, Inc. reported a 15.30% year-over-year revenue growth, a Gross Profit Margin of 79.53% (TTM), a Debt-to-Equity ratio of 0.36x, a Price-to-Sales (P/S) ratio of 3.40x (TTM), a Price-to-Book (P/B) ratio of 3.98x (TTM), at a market cap of $725.87M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 15.30%
- Gross Profit Margin TTM
- 79.53%
- Debt To Equity
- 0.36x
- P/S TTM
- 3.40x
- P/B TTM
- 3.98x
- Market Cap
- $725.87M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is SI-BONE, Inc. in?
SI-BONE, Inc. (SIBN) operates in the Surgical & Medical Instruments & Apparatus industry.
What is SIBN's market cap?
SI-BONE, Inc. (SIBN) has a market capitalization of $725.87M as of 2026-06-30.
What exchange does SIBN trade on?
SI-BONE, Inc. (SIBN) trades on the Nasdaq.
Where is SI-BONE, Inc. incorporated?
SI-BONE, Inc. is incorporated in DE.